Advertisement

Topics

High Potency Active Pharmaceutical Ingredients HPAPI Global Market Forecast To 2023 [Report Updated: 07112017] Prices from USD $4950

08:58 EST 14 Nov 2017 | BioPortfolio Report Blog

The drugs are classified as High Potent if its Occupational Exposure Limit OELs 10g/m3.The HPAPI global market is progressively increasing in terms of revenue and the rise in demand for outsourcing these intermediates, manufacturing is driven by expansion of oncology sector, which is the fastest among overall pharmaceutical sector.

The global HPAPI market is valued to be $XX million in 2016 and poised to grow at a CAGR of X% to reach $27,293.4 million by 2023. HPAPI market is mainly classified by customer base, by business type, by molecule type and Applications. The global HPAPI market is broadly classified as Innovative HPAPI and Generic HPAPI based on customer base. Based on business type, the market is classified into Captive HPAPI Merchant HPAPI. HPAPI market is segmented on the basis of molecule type as Synthetic HPAPI and Biotech HPAPI. HPAPI market application segment is classified into Oncology, Cardiovascular, Central Nervous System, Hormonal, Glaucoma, Infectious, metabolic, Inflammation and other therapeutic applications.

Among Innovative generic HPAPI, Innovative HPAPI occupies the major share in 2016 and generic HPAPIs expected to grow at a highest CAGR from 2016 to 2023. Among business type, Captive HPAPI occupies the major share of XX% in 2016 and Merchant HPAPI is expected to grow at a highest CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among molecule type, Synthetic HPAPI occupies the major share in 2016 and is expected to grow at a CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among Application segment, Oncology commanded the larger revenue of $XX million in 2016 and is expected to grow at a highest CAGR of X% from 2016 to 2023.

Increasing incidence of chronic and age related diseases, rapid growth in oncology market, growing demand for Antibody Drug Conjugates ADC, technological advancements in HPAPI market, growing CMOs are some of the factors which are driving the market. Requirement of large investments, stringent safety and handling specifications associated with production of HPAPI, stringent regulations are the factors hindering the market.

North America accounts for the highest market share in 2016 and followed by Europe. However, Asian countries especially China and India are the fastest growing regions with its growing demand for HPAPIs. AsiaPacific is projected to grow with a highest CAGR of XX% from 2016 to 2023.

Major players in HPAPI market include Alkermes plc Ireland,Cambrex Corporation U.S.,Dishman group India, Dr. Reddy's Laboratories India, Lonza Group Switzerland, Novasep U.S., Patheon N.V. NetherlandThermoFisher Scientific, Pfizer U.S., Merck KGaA Germany and Teva Pharmaceutical Industries Israel.

The report provides an in depth market analysis of the above mentioned segments across the following regions:

North America

Europe

AsiaPacific

Rest of the World

Original Article: High Potency Active Pharmaceutical Ingredients HPAPI Global Market Forecast To 2023 [Report Updated: 07112017] Prices from USD $4950

NEXT ARTICLE

More From BioPortfolio on "High Potency Active Pharmaceutical Ingredients HPAPI Global Market Forecast To 2023 [Report Updated: 07112017] Prices from USD $4950"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...